Literature DB >> 25453777

Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.

C C Trandafir1, W A Pouliot1, F E Dudek1, J J Ekstrand2.   

Abstract

RATIONALE: Seizures during status epilepticus (SE) cause neuronal death and induce cyclooxygenase-2 (COX-2). Pilocarpine-induced SE was used to determine if COX-2 inhibition with NS-398, when administered alone or with diazepam, decreases the duration and/or intensity of SE and/or reduces neuronal injury in the rat hippocampus.
METHODS: Electroencephalogram (EEG) electrodes were implanted in male Sprague-Dawley rats. SE was induced with lithium-pilocarpine, and continuous EEG and video monitoring were performed for 24 h. Rats were divided into four groups (n=8-14 rats/group) and received NS-398, diazepam, NS-398 and diazepam, or vehicle 30 min after the first motor seizure. Six hours later, NS-398 injection was repeated in the NS-398 and in the NS-398+diazepam groups. The duration of SE (continuous spiking) and the EEG power in the γ-band were analyzed. FluoroJade B staining in the dorsal hippocampus at 24h after SE was analyzed semi-quantitatively in the CA1, CA3 and hilus.
RESULTS: The duration and intensity of electrographic SE was not significantly different across the four groups. In rats treated with NS-398 alone, compared to vehicle-treated rats, neuronal damage was significantly lower compared to vehicle-treated rats in the CA3 (27%) and hilus (27%), but neuroprotection was not detected in the CA1. When NS-398 was administered with diazepam, decreased neuronal damage was further obtained in all areas investigated (CA1: 61%, CA3: 63%, hilus: 60%).
CONCLUSIONS: NS-398, when administered 30 min after the onset of SE with a repeat dose at 6h, decreased neuronal damage in the hippocampus. Administration of diazepam with NS-398 potentiates the neuroprotective effect of the COX-2 inhibitor. These neuroprotective effects occurred with no detectable effect on electrographic SE.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cyclooxygenase-2 (COX-2); inflammation; neuroprotection

Mesh:

Substances:

Year:  2014        PMID: 25453777      PMCID: PMC4326254          DOI: 10.1016/j.neuroscience.2014.10.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

Review 2.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

3.  Antipyretic effect of phytol, possibly via 5KIR-dependent COX-2 inhibition pathway.

Authors:  Muhammad Torequl Islam
Journal:  Inflammopharmacology       Date:  2019-02-18       Impact factor: 4.473

Review 4.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Authors:  Avijit Dey; Xu Kang; Jiange Qiu; Yifeng Du; Jianxiong Jiang
Journal:  Trends Pharmacol Sci       Date:  2016-04-06       Impact factor: 14.819

Review 5.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

6.  Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.

Authors:  Asheebo Rojas; Wenyi Wang; Avery Glover; Zahra Manji; Yujiao Fu; Raymond Dingledine
Journal:  eNeuro       Date:  2018-04-17

7.  A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force.

Authors:  Melissa Barker-Haliski; Lauren C Harte-Hargrove; Teresa Ravizza; Ilse Smolders; Bo Xiao; Claudia Brandt; Wolfgang Löscher
Journal:  Epilepsia Open       Date:  2018-09-15

Review 8.  Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management.

Authors:  Chitra Rawat; Samiksha Kukal; Ujjwal Ranjan Dahiya; Ritushree Kukreti
Journal:  J Neuroinflammation       Date:  2019-10-30       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.